Showing 1 - 20 results of 41 for search 'Joseph L. Witztum', query time: 0.05s Refine Results
  1. 1
    Thematic Reviews on the Pathogenesis of Atherosclerosis

    Thematic Reviews on the Pathogenesis of Atherosclerosis by Joseph L. Witztum

    Published 2004-06-01
    Get full text
    Article
  2. 2
    New Commentary section to highlight significant JLR articles

    New Commentary section to highlight significant JLR articles by Edward A. Dennis, Joseph L. Witztum

    Published 2008-01-01
    Get full text
    Article
  3. 3
    Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements

    Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements by Calvin Yeang, Joseph L. Witztum, Sotirios Tsimikas

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors

    Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors by Kristin L. Gillotte, Sohvi Hörkkö, Joseph L. Witztum, Daniel Steinberg

    Published 2000-05-01
    Get full text
    Article
  5. 5
    Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein

    Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein by Kristin Gillotte-Taylor, Agnès Boullier, Joseph L. Witztum, Daniel Steinberg, Oswald Quehenberger

    Published 2001-09-01
    Get full text
    Article
  6. 6
    In Memoriam: Roger A. Davis (1945–2008)

    In Memoriam: Roger A. Davis (1945–2008) by Alan D. Attie, Joseph L. Witztum, Peter A. Edwards, A. Jake Lusis

    Published 2008-11-01
    Get full text
    Article
  7. 7
    Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet

    Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet by Nastaran Faghihnia, Sotirios Tsimikas, Elizabeth R. Miller, Joseph L. Witztum, Ronald M. Krauss

    Published 2010-11-01
    Get full text
    Article
  8. 8
    Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)

    Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a) by Santica M. Marcovina, Nazanin Navabi, Serena Allen, Ayelet Gonen, Joseph L. Witztum, Sotirios Tsimikas

    Published 2022-08-01
    Get full text
    Article
  9. 9
    Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach

    Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and dec... by Lars Berglund, Joseph L. Witztum, Narmer F. Galeano, Andrew S. Khouw, Henry N. Ginsberg, Rajasekhar Ramakrishnan

    Published 1998-04-01
    Get full text
    Article
  10. 10
    Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors

    Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors by Erica N. Montano, Agnès Boullier, Felicidad Almazan, Christoph J. Binder, Joseph L. Witztum, Karsten Hartvigsen

    Published 2013-11-01
    Get full text
    Article
  11. 11
    In memoriam: Judith A. Berliner, Ph.D.

    In memoriam: Judith A. Berliner, Ph.D. by Mete Civelek, Alan M. Fogelman, Catherine C. Hedrick, Aldons J. Lusis, Casey E. Romanoski, Joseph L. Witztum

    Published 2022-04-01
    Get full text
    Article
  12. 12
    Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice

    Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice by Catherine A. Reardon, Elizabeth R. Miller, Lydia Blachowicz, John Lukens, Christoph J. Binder, Joseph L. Witztum, Godfrey S. Getz

    Published 2004-07-01
    Get full text
    Article
  13. 13
    The role of innate immunity in atherogenesis1

    The role of innate immunity in atherogenesis1 by Karsten Hartvigsen, Meng-Yun Chou, Lotte F. Hansen, Peter X. Shaw, Sotirios Tsimikas, Christoph J. Binder, Joseph L. Witztum

    Published 2009-01-01
    Get full text
    Article
  14. 14
    The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis

    The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis by Peng Zhao, Xiaoli Sun, Zhongji Liao, Hong Yu, Dan Li, Zeyang Shen, Christopher K. Glass, Joseph L. Witztum, Alan R. Saltiel

    Published 2022-09-01
    Get full text
    Article
  15. 15
    Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1

    Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1 by Kiyohito Arai, Alexina Orsoni, Ziad Mallat, Alain Tedgui, Joseph L. Witztum, Eric Bruckert, Alexandros D. Tselepis, M. John Chapman, Sotirios Tsimikas

    Published 2012-08-01
    Get full text
    Article
  16. 16
    Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

    Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events by Sotirios Tsimikas, Emmanouil S. Brilakis, Ryan J. Lennon, Elizabeth R. Miller, Joseph L. Witztum, Joseph P. McConnell, Kenneth S. Kornman, Peter B. Berger

    Published 2007-02-01
    Get full text
    Article
  17. 17
    High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction

    High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction by Adam Taleb, Peter Willeit, Shahzada Amir, Thomas Perkmann, Maria Ozsvar Kozma, Martin L. Watzenböck, Christoph J. Binder, Joseph L. Witztum, Sotirios Tsimikas

    Published 2023-06-01
    Get full text
    Article
  18. 18
    Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease

    Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease by Shahzada Amir, Karsten Hartvigsen, Ayelet Gonen, Gregor Leibundgut, Xuchu Que, Erika Jensen-Jarolim, Oswald Wagner, Sotirios Tsimikas, Joseph L. Witztum, Christoph J. Binder

    Published 2012-07-01
    Get full text
    Article
  19. 19
    Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results1

    Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results1 by Xiaohong Yang, Sang-Rok Lee, Yun-Seok Choi, Veronica J. Alexander, Andres Digenio, Qingqing Yang, Yury I. Miller, Joseph L. Witztum, Sotirios Tsimikas

    Published 2016-04-01
    Get full text
    Article
  20. 20
    Phosphocholine as a pattern recognition ligand for CD361

    Phosphocholine as a pattern recognition ligand for CD361 by Agnès Boullier, Peter Friedman, Richard Harkewicz, Karsten Hartvigsen, Simone R. Green, Felicidad Almazan, Edward A. Dennis, Daniel Steinberg, Joseph L. Witztum, Oswald Quehenberger

    Published 2005-05-01
    Get full text
    Article

Search Tools: